Overall Status

Completed (35)

Terminated (14)

Withdrawn (3)

Active, not recruiting (1)

Enrolling by invitation (1)

Not yet recruiting (1)

Recruiting (1)

Phase

phase 1 (21)

phase 2 (20)

phase 1/phase 2 (5)

n/a (3)

phase 3 (2)

early phase 1 (1)

Sponsor

National Cancer Institute (NCI) (37)

Gynecologic Oncology Group (6)

National Institutes of Health Clinical Center (CC) (5)

Sarcoma Alliance for Research through Collaboration (3)

Children's Oncology Group (2)

Acrotech Biopharma Inc. (1)

Hoffmann-La Roche (1)

University of Alabama at Birmingham (1)

Collaborator

National Cancer Institute (NCI) (15)

United States Department of Defense (3)

Genentech, Inc. (1)

National Center for Complementary and Integrative Health (NCCIH) (1)

Novartis Pharmaceuticals (1)

Sarcoma Alliance for Research through Collaboration (1)

Synta Pharmaceuticals Corp. (1)

Study Documents

Intervention Type

drug (43)

biological (15)

procedure (9)

other (3)

radiation (2)

behavioral (1)

Funder Type

NIH (42)

Other (12)

Industry (2)

Study Type

Interventional (52)

Observational (4)

sarcoma

Showing NaN - NaN of 56

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED